New JV from Upstart Biotechs Pyxis, Alloy Aims for Rapid Drug Development in Cancer, Autoimmune Diseases May 26, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases May 25, 2021
Pyxis Oncology Presents Preclinical Data and Details on Antibody-Drug Conjugate Candidates Supporting Therapeutic Potential April 27, 2021
Armed with Pfizer’s ADC Platform, Pyxis Scores $152M Round to Shoot for the Clinic while Taking its Time on I/O Programs April 2, 2021